FORTY Q1 2025 Earnings EPS of 123 Reported Amid Stock Decline Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus UZD Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gains CABA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Autoimmune Pipeline American Rebel Holdings Inc AREB Q1 2026 Earnings Significant Net Loss Amid Lack of Revenue IN8bio Q1 2026 Earnings Narrowed Loss Beats Expectations as Development Pipeline Advances